Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial

2016258 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Respiratory Medicine

Volume 4, Issue 10, pp. 797-806

Field-Weighted Citation Impact: 16.77